Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Current Assets (2016 - 2026)

Biomerica's Current Assets history spans 16 years, with the latest figure at $4.1 million for Q1 2026.

  • On a quarterly basis, Current Assets fell 33.54% to $4.1 million in Q1 2026 year-over-year; TTM through Feb 2026 was $4.1 million, a 33.54% decrease, with the full-year FY2025 number at $4.9 million, down 36.94% from a year prior.
  • Current Assets hit $4.1 million in Q1 2026 for Biomerica, down from $5.2 million in the prior quarter.
  • Over the last five years, Current Assets for BMRA hit a ceiling of $15.2 million in Q1 2022 and a floor of $4.1 million in Q1 2026.
  • Historically, Current Assets has averaged $8.1 million across 5 years, with a median of $7.7 million in 2024.
  • Biggest five-year swings in Current Assets: soared 41.23% in 2022 and later tumbled 57.44% in 2023.
  • Tracing BMRA's Current Assets over 5 years: stood at $8.1 million in 2022, then increased by 26.75% to $10.3 million in 2023, then tumbled by 42.08% to $5.9 million in 2024, then dropped by 12.68% to $5.2 million in 2025, then decreased by 20.57% to $4.1 million in 2026.
  • Business Quant data shows Current Assets for BMRA at $4.1 million in Q1 2026, $5.2 million in Q4 2025, and $5.9 million in Q3 2025.